Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1985 1
1986 1
1988 2
1990 2
1992 1
1994 4
1995 1
1997 1
1998 1
1999 2
2000 4
2001 4
2002 3
2003 5
2004 4
2005 3
2006 3
2007 7
2008 2
2009 9
2010 5
2011 3
2012 2
2014 2
2015 8
2016 10
2017 7
2018 10
2019 9
2020 14
2021 26
2022 28
2023 40
2024 50
2025 46
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A, Yanagisawa T, Bekku K, Kardoust Parizi M, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Fazekas T, Miszczyk M, Miki J, Kimura T, Karakiewicz PI, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: miki j. Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4. Eur Urol Oncol. 2024. PMID: 38182488 Free article.
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.
Matsukawa A, Litterio G, Cormio A, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Laukhtina E, Rajwa P, Mori K, Chlosta P, Marchioni M, Schips L, Miki J, Kimura T, Shariat SF, Yanagisawa T. Matsukawa A, et al. Among authors: miki j. Cancers (Basel). 2025 Jan 9;17(2):205. doi: 10.3390/cancers17020205. Cancers (Basel). 2025. PMID: 39857987 Free PMC article. Review.
Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis.
Matsukawa A, Yanagisawa T, Parizi MK, Laukhtina E, Klemm J, Fazekas T, Mori K, Kimura S, Briganti A, Ploussard G, Karakiewicz PI, Miki J, Kimura T, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: miki j. Prostate Cancer Prostatic Dis. 2025 Jun;28(2):298-308. doi: 10.1038/s41391-024-00886-0. Epub 2024 Sep 5. Prostate Cancer Prostatic Dis. 2025. PMID: 39237679 Free PMC article.
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort.
Saito R, Taoka R, Miki J, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kinoshita H; Japan Urological Oncology Group. Saito R, et al. Among authors: miki j. Int J Clin Oncol. 2025 Oct;30(10):2106-2117. doi: 10.1007/s10147-025-02833-y. Epub 2025 Jul 21. Int J Clin Oncol. 2025. PMID: 40690100
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer management.
Goto Y, Urabe F, Ogihara Y, Nakata M, Nakano J, Fujiwara K, Hashimoto M, Koike Y, Iwamoto Y, Miyajima K, Fukuokaya W, Iwatani K, Imai Y, Inaba Y, Ito K, Yanagisawa T, Murakami M, Tashiro K, Watanabe K, Miki J, Kimura T; JIKEI‐YAYOI Collaborative Group. Goto Y, et al. Among authors: miki j. BJU Int. 2025 Nov;136(5):902-910. doi: 10.1111/bju.16860. Epub 2025 Jul 19. BJU Int. 2025. PMID: 40682449
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.
Urabe F, Imai Y, Goto Y, Tashiro K, Hashimoto M, Yoshihara K, Yamamoto S, Hara S, Miyajima K, Fukuokaya W, Enei Y, Iwatani K, Kayano S, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Tsuzuki S, Murakami M, Hata K, Shimomura T, Yamada H, Miki J, Kimura T. Urabe F, et al. Among authors: miki j. Jpn J Clin Oncol. 2024 Nov 2;54(11):1208-1213. doi: 10.1093/jjco/hyae098. Jpn J Clin Oncol. 2024. PMID: 39037966 Free article.
Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis.
Matsukawa A, Yanagisawa T, Bekku K, Parizi MK, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Miki J, Pradere B, Rivas JG, Gandaglia G, Kimura T, Kasivisvanathan V, Ploussard G, Cornford P, Shariat SF, Rajwa P. Matsukawa A, et al. Among authors: miki j. Eur Urol Oncol. 2024 Jun;7(3):376-400. doi: 10.1016/j.euo.2023.10.010. Epub 2023 Oct 28. Eur Urol Oncol. 2024. PMID: 38277189 Free article.
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates.
Yanagisawa T, Matsukawa A, Teoh JY, Mori K, Kawada T, Katayama S, Rajwa P, Quhal F, Pradere B, Moschini M, Shariat SF, Miki J, Kimura T. Yanagisawa T, et al. Among authors: miki j. Bladder Cancer. 2025 Apr 25;11(2):23523735251335122. doi: 10.1177/23523735251335122. eCollection 2025 Apr-Jun. Bladder Cancer. 2025. PMID: 40296876 Free PMC article. Review.
Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.
Sazuka T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Sawada A, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ichikawa T; Japan Urological Oncology Group. Sazuka T, et al. Among authors: miki j. Int J Clin Oncol. 2025 Jul;30(7):1417-1425. doi: 10.1007/s10147-025-02778-2. Epub 2025 May 10. Int J Clin Oncol. 2025. PMID: 40347426
Impact of Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis.
Matsukawa A, Cormio A, Miszczyk M, Parizi MK, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Litterio G, Laukhtina E, Rajwa P, Seisen T, Mori K, Sanguedolce F, Galosi AB, Miki J, Kimura T, Shariat SF, Yanagisawa T. Matsukawa A, et al. Among authors: miki j. Eur Urol Oncol. 2025 Dec;8(6):1673-1684. doi: 10.1016/j.euo.2025.02.009. Epub 2025 Apr 26. Eur Urol Oncol. 2025. PMID: 40288918
290 results